IPCA LABORATORIES
Back to Cashflow Statement
|
IPCA LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-553 Cr | ₹507 Cr | ₹427 Cr | ₹-306 Cr | ₹-137 Cr |
What is the latest Cash Flow from Financing Activities ratio of IPCA LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-553 Cr |
Mar2023 | ₹507 Cr |
Mar2022 | ₹427 Cr |
Mar2021 | ₹-306 Cr |
Mar2020 | ₹-137 Cr |
How is Cash Flow from Financing Activities of IPCA LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-553 Cr | Negative | |
Mar2023 | ₹507 Cr | 18.85 | |
Mar2022 | ₹427 Cr | Positive | |
Mar2021 | ₹-306 Cr | Negative | |
Mar2020 | ₹-137 Cr | - |
Compare Cash Flow from Financing Activities of peers of IPCA LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
IPCA LABORATORIES | ₹34,758.2 Cr | -3.7% | 1.5% | 23.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
IPCA LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
IPCA LABORATORIES | -3.7% |
1.5% |
23.1% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses